• Home
  • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Coins2Day 500
    • Coins2Day 500 U.S.
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
  • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  • Home
  • Latest
    • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day 500 U.S.
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
  • Finance
    • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  1. home
  1. home
  2. precision medicine

precision medicine

Page 2 of 2

View of stethoscope on table in laboratory
Commentary

Can Your Genes Really Predict the Future of Your Health?

By Sandro Galea
June 9, 2016
Inside The Pfizer Inc. Kendall Square Research Facility Ahead Of Earnings Figures
Health

Cancer Drugs Are The Least Likely to Receive FDA Approval

By Sy Mukherjee
May 26, 2016
Intel Reports Quarterly Earnings
Tech

Intel’s Cancer Cloud Gets New Recruits

By Jonathan Vanian
March 31, 2016
Israeli PM Netanyahu Meets Obama At The White House
Commentary

What Obama’s SOTU Should Say About Personalized Medicine

By Vivian Lee
January 12, 2016
A Secret Service officer mans his post o
Tech

The White House has a plan to help society through data analysis

By Derrick Harris
September 30, 2015
2012 U.S. Olympic Track & Field Team Trials - Day 9
Leadership

Nike’s Phil Knight donating $500 million to cancer research

By Laura Lorenzetti
June 25, 2015
Cancer drug spending hit $100 billion in 2014. Here’s why it’ll soon be much higher
Features

Cancer drug spending hit $100 billion in 2014. Here’s why it’ll soon be much higher

By Laura Lorenzetti
May 8, 2015

Most Popular

  • Economy
    Treasury spent $276 billion in interest on the national debt in the final three months of 2025, says the CBO—up $30...
    By Eleanor Pringle
  • Economy
    ‘Sell America’: Investors dump U.S. assets in fear of the end of Fed independence
    By Jim Edwards
  • Success
    An exec at $62 billion giant Colgate says Gen Z workers, despite getting flak for being woke and lazy, are actually...
    By Emma Burleigh
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Coins2Day
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.